BOEING CO/THE (BA) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:BA • US0970231058

237.02 USD
+1.07 (+0.45%)
At close: Feb 5, 2026
236.95 USD
-0.07 (-0.03%)
After Hours: 2/5/2026, 4:02:02 PM
Fundamental Rating

2

Taking everything into account, BA scores 2 out of 10 in our fundamental rating. BA was compared to 72 industry peers in the Aerospace & Defense industry. BA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, BA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • BA had negative earnings in the past year.
  • BA had a positive operating cash flow in the past year.
  • In the past 5 years BA reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: BA reported negative operating cash flow in multiple years.
BA Yearly Net Income VS EBIT VS OCF VS FCFBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B

1.2 Ratios

  • BA has a Return On Assets (1.12%) which is in line with its industry peers.
  • The Return On Equity of BA (34.65%) is better than 97.22% of its industry peers.
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROIC N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BA Yearly ROA, ROE, ROICBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.11%, BA is in line with its industry, outperforming 51.39% of the companies in the same industry.
  • The Gross Margin of BA (4.79%) is worse than 79.17% of its industry peers.
  • BA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 2.11%
GM 4.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
BA Yearly Profit, Operating, Gross MarginsBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BA has been increased compared to 5 years ago.
  • BA has a better debt/assets ratio than last year.
BA Yearly Shares OutstandingBA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
BA Yearly Total Debt VS Total AssetsBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • BA has an Altman-Z score of 1.38. This is a bad value and indicates that BA is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.38, BA is not doing good in the industry: 73.61% of the companies in the same industry are doing better.
  • BA has a Debt/Equity ratio of 8.37. This is a high value indicating a heavy dependency on external financing.
  • BA has a worse Debt to Equity ratio (8.37) than 86.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Altman-Z 1.38
ROIC/WACCN/A
WACC10.18%
BA Yearly LT Debt VS Equity VS FCFBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • BA has a Current Ratio of 1.19. This is a normal value and indicates that BA is financially healthy and should not expect problems in meeting its short term obligations.
  • BA has a worse Current ratio (1.19) than 80.56% of its industry peers.
  • A Quick Ratio of 0.40 indicates that BA may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.40, BA is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.4
BA Yearly Current Assets VS Current LiabilitesBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 49.34% over the past year.
  • Looking at the last year, BA shows a very strong growth in Revenue. The Revenue has grown by 34.50%.
  • Measured over the past years, BA shows a quite strong growth in Revenue. The Revenue has been growing by 8.81% on average per year.
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%

3.2 Future

  • BA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.74% yearly.
  • The Revenue is expected to grow by 9.94% on average over the next years. This is quite good.
EPS Next Y101.96%
EPS Next 2Y57.38%
EPS Next 3Y42.54%
EPS Next 5Y26.74%
Revenue Next Year9.4%
Revenue Next 2Y12.12%
Revenue Next 3Y11.24%
Revenue Next 5Y9.94%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BA Yearly Revenue VS EstimatesBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B
BA Yearly EPS VS EstimatesBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 -10 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • BA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • BA is valuated quite expensively with a Price/Forward Earnings ratio of 1172.45.
  • BA's Price/Forward Earnings ratio is in line with the industry average.
  • BA is valuated expensively when we compare the Price/Forward Earnings ratio to 27.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1172.45
BA Price Earnings VS Forward Price EarningsBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800 1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BA Per share dataBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as BA's earnings are expected to grow with 42.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.38%
EPS Next 3Y42.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BOEING CO/THE

NYSE:BA (2/5/2026, 4:02:02 PM)

After market: 236.95 -0.07 (-0.03%)

237.02

+1.07 (+0.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-27
Earnings (Next)04-21
Inst Owners71.79%
Inst Owner Change-0.65%
Ins Owners0.03%
Ins Owner Change0.2%
Market Cap180.16B
Revenue(TTM)89.46B
Net Income(TTM)1.89B
Analysts83.78
Price Target276.16 (16.51%)
Short Float %2.19%
Short Ratio1.91
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.43
Dividend Growth(5Y)-36.84%
DP17.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-118.5%
Min EPS beat(2)-179.06%
Max EPS beat(2)-57.93%
EPS beat(4)2
Avg EPS beat(4)-38.78%
Min EPS beat(4)-179.06%
Max EPS beat(4)63.2%
EPS beat(8)4
Avg EPS beat(8)-30.95%
EPS beat(12)6
Avg EPS beat(12)-17.74%
EPS beat(16)6
Avg EPS beat(16)-664.18%
Revenue beat(2)2
Avg Revenue beat(2)2.86%
Min Revenue beat(2)2.82%
Max Revenue beat(2)2.89%
Revenue beat(4)3
Avg Revenue beat(4)1.03%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)2.89%
Revenue beat(8)3
Avg Revenue beat(8)-1.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.94%
Revenue beat(16)5
Avg Revenue beat(16)-3.25%
PT rev (1m)2.09%
PT rev (3m)-0.06%
EPS NQ rev (1m)-369.84%
EPS NQ rev (3m)-130.5%
EPS NY rev (1m)-4.5%
EPS NY rev (3m)-41.02%
Revenue NQ rev (1m)-1.29%
Revenue NQ rev (3m)-1.37%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)-0.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1172.45
P/S 2.01
P/FCF N/A
P/OCF 169.16
P/B 33.03
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.32
EYN/A
EPS(NY)0.2
Fwd EY0.09%
FCF(TTM)-2.48
FCFYN/A
OCF(TTM)1.4
OCFY0.59%
SpS117.7
BVpS7.18
TBVpS-17.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.11%
GM 4.79%
FCFM N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.1%
Cap/Sales 3.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.4
Altman-Z 1.38
F-Score6
WACC10.18%
ROIC/WACCN/A
Cap/Depr(3y)119.8%
Cap/Depr(5y)93.37%
Cap/Sales(3y)2.92%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
EPS Next Y101.96%
EPS Next 2Y57.38%
EPS Next 3Y42.54%
EPS Next 5Y26.74%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%
Revenue Next Year9.4%
Revenue Next 2Y12.12%
Revenue Next 3Y11.24%
Revenue Next 5Y9.94%
EBIT growth 1Y49.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year279.12%
EBIT Next 3Y74.28%
EBIT Next 5Y46.92%
FCF growth 1Y86.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.82%
OCF growth 3Y-32.82%
OCF growth 5YN/A

BOEING CO/THE / BA FAQ

What is the ChartMill fundamental rating of BOEING CO/THE (BA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BA.


What is the valuation status for BA stock?

ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BA). This can be considered as Overvalued.


Can you provide the profitability details for BOEING CO/THE?

BOEING CO/THE (BA) has a profitability rating of 2 / 10.


Is the dividend of BOEING CO/THE sustainable?

The dividend rating of BOEING CO/THE (BA) is 0 / 10 and the dividend payout ratio is 17.51%.